Major cancer drugs could become cheaper as India considers import duty waiver

Major cancer drugs could become cheaper as India considers import duty waiver

The documents show that blockbuster cancer drugs like pembrolizumab (brand Keytruda), osimertinib (brand Tagrisso), and trastuzumab deruxtecan (brand Enhertu), used to treat lung and breast cancer, will be fully exempted from customs duty